TY - JOUR
T1 - Purging of Autologous Bone Marrow for Transplantation
T2 - The Protection and Selection of the Hematopoietic Progenitor Cell
AU - Shpall, Elizabeth J.
AU - Stemmer, Salomon M.
AU - Johnston, Charles F.
AU - Hami, Lisa
AU - Bearman, Scott I.
AU - Berenson, Ronald
AU - Jones, Roy B.
N1 - Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 1992
Y1 - 1992
N2 - Autologous bone marrow transplantation (ABMT) is the treatment of choice for selected patients with acute myelogenous leukemia, non-Hodgkin's lymphoma, and poor prognosis breast cancer. A possible limitation of this approach is that clonogenic tumor cells could be collected and infused back into the patient along with the normal bone marrow. The major emphasis in our laboratory has been the development of marrow purging regimens for breast cancer patients. This paper describes two investigative approaches hematopoietic progenitor cell protection and selection. We describe how the use of G-CSF in the patients who receive positively selected marrow shortens the rate of engraftment.
AB - Autologous bone marrow transplantation (ABMT) is the treatment of choice for selected patients with acute myelogenous leukemia, non-Hodgkin's lymphoma, and poor prognosis breast cancer. A possible limitation of this approach is that clonogenic tumor cells could be collected and infused back into the patient along with the normal bone marrow. The major emphasis in our laboratory has been the development of marrow purging regimens for breast cancer patients. This paper describes two investigative approaches hematopoietic progenitor cell protection and selection. We describe how the use of G-CSF in the patients who receive positively selected marrow shortens the rate of engraftment.
UR - http://www.scopus.com/inward/record.url?scp=0026840335&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026840335&partnerID=8YFLogxK
U2 - 10.1089/scd.1.1992.1.45
DO - 10.1089/scd.1.1992.1.45
M3 - Article
C2 - 1365017
AN - SCOPUS:0026840335
SN - 1525-8165
VL - 1
SP - 45
EP - 54
JO - Journal of Hematotherapy and Stem Cell Research
JF - Journal of Hematotherapy and Stem Cell Research
IS - 1
ER -